Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase

Michael Copeman

Correspondence:

1. Law MG, Batey RG. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase. Med J Aust 2003; 178: 197-198. <eMJA full text>
2. Commonwealth Department of Health and Ageing. Return on investment in needle and syringe programs in Australia. Canberra: Department of Health and Ageing, 2002. Available at: http://www.health.gov.au/pubhlth/publicat/hac.htm (accessed Jun 2003).

Online responses are no longer available. Please refer to our instructions for authors page for more information.